Compass Therapeutics financial statements

컴퍼스 테라퓨틱스NASDAQ:CMPX · Nasdaq · Healthcare · sector #13
$0.9606+12.13%
2026-10-05 close

Compass Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$57M.

Reported results

Compass Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q